Global Liver Disease Drug Market Research Report 2021

July 2016 | 125 pages | ID: G3316AD23CEEN
QYResearch

Abstracts

This report studies Liver Disease Drug in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Bayer Schering AG
• Biotest
• Bristol-Myers Squibb
• Eli Lilly
• Glaxosmithkline PlC
• Merck & Co
• Pfizer
• Roche
• Valeant Pharmaceuticals International, Inc
• Chia Tai Tianqing Pharmaceutical Group
• Fujian Cosunter Pharmaceutical Company
• Beijing Sl Pharmaceutical Co., Ltd.
• Inner Mongolia Furui Medical Science Co. Ltd.

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Liver Disease Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Liver Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Liver Disease Drug Market Research Report 2021

1 LIVER DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Liver Disease Drug
1.2 Liver Disease Drug Segment by Types
  1.2.1 Global Sales Market Share of Liver Disease Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Liver Disease Drug Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Liver Disease Drug Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Liver Disease Drug (2011-2021)
  1.5.1 Global Liver Disease Drug Sales and Revenue (2011-2021)
  1.5.2 Global Liver Disease Drug Sales and Growth Rate (2011-2021)
  1.5.3 Global Liver Disease Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL LIVER DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Liver Disease Drug Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Liver Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Liver Disease Drug Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL LIVER DISEASE DRUG ANALYSIS BY REGION

3.1 Global Liver Disease Drug Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Liver Disease Drug Sales Market Share by Region (2011-2021)
  3.1.2 Global Liver Disease Drug Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.2.2 North America Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.4.2 China Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.6.2 India Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Liver Disease Drug Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL LIVER DISEASE DRUG ANALYSIS BY TYPE

4.1 Global Liver Disease Drug Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Liver Disease Drug Sales and Market Share by Type (2011-2021)
  4.1.2 Global Liver Disease Drug Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL LIVER DISEASE DRUG MARKET ANALYSIS BY APPLICATION

5.1 Global Liver Disease Drug Sales and Market Share by Application (2011-2021)
5.2 Major Regions Liver Disease Drug Sales by Application in 2015 and 2016
  5.2.1 North America Liver Disease Drug Sales by Application
  5.2.2 Europe Liver Disease Drug Sales by Application
  5.2.3 China Liver Disease Drug Sales by Application
  5.2.4 Japan Liver Disease Drug Sales by Application
  5.2.5 India Liver Disease Drug Sales by Application
  5.2.6 Southeast Asia Liver Disease Drug Sales by Application

6 GLOBAL LIVER DISEASE DRUG MANUFACTURERS ANALYSIS

6.1 Bayer Schering AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liver Disease Drug Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Liver Disease Drug Sales, Revenue, Price of Bayer Schering AG (2015 and 2016)
6.2 Biotest
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Liver Disease Drug Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Liver Disease Drug Sales, Revenue, Price of Biotest (2015 and 2016)
6.3 Bristol-Myers Squibb
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Liver Disease Drug Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Liver Disease Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
6.4 Eli Lilly
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Liver Disease Drug Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Liver Disease Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
6.5 Glaxosmithkline PlC
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Liver Disease Drug Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Liver Disease Drug Sales, Revenue, Price of Glaxosmithkline PlC (2015 and 2016)
6.6 Merck & Co
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Liver Disease Drug Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Liver Disease Drug Sales, Revenue, Price of Merck & Co (2015 and 2016)
6.7 Pfizer
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Liver Disease Drug Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Liver Disease Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
6.8 Roche
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Liver Disease Drug Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Liver Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
6.9 Valeant Pharmaceuticals International, Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Liver Disease Drug Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Liver Disease Drug Sales, Revenue, Price of Valeant Pharmaceuticals International, Inc (2015 and 2016)
6.10 Chia Tai Tianqing Pharmaceutical Group
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Liver Disease Drug Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Liver Disease Drug Sales, Revenue, Price of Chia Tai Tianqing Pharmaceutical Group (2015 and 2016)
6.11 Fujian Cosunter Pharmaceutical Company
6.12 Beijing Sl Pharmaceutical Co., Ltd.
6.13 Inner Mongolia Furui Medical Science Co. Ltd.

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liver Disease Drug
Figure Global Sales Market Share of Liver Disease Drug by Type in 2015
Table Liver Disease Drug Product Type of by Manufacturers
Table Liver Disease Drug Sales Market Share by Application in 2015 and 2016
Figure North America Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure China Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Japan Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure India Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Liver Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Liver Disease Drug Sales and Revenue (2011-2021)
Figure Global Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Global Liver Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Liver Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table Global Liver Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liver Disease Drug Sales Share by Manufacturers
Figure 2016 Liver Disease Drug Sales Share by Manufacturers
Table Global Liver Disease Drug Revenue by Manufacturers (2015 and 2016)
Table Global Liver Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Liver Disease Drug Revenue Share by Manufacturers
Table 2016 Global Liver Disease Drug Revenue Share by Manufacturers
Table Manufacturers Liver Disease Drug Manufacturing Base Distribution and Product Type
Table Global Liver Disease Drug Sales Market by Region (2011-2021)
Figure Global Liver Disease Drug Sales Market by Region (2011-2021)
Figure Global Liver Disease Drug Sales Market Share by Region (2011-2021)
Table Global Liver Disease Drug Revenue Market by Region (2011-2021)
Table Global Liver Disease Drug Revenue Market Share by Region (2011-2021)
Table North America Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure North America Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Europe Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure Europe Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table China Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure China Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Japan Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure Japan Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table India Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure India Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Liver Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Global Liver Disease Drug Sales by Type (2011-2021)
Table Global Liver Disease Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Liver Disease Drug by Type (2011-2021)
Figure Global Liver Disease Drug Sales Growth Rate by Type (2011-2021)
Table Global Liver Disease Drug Revenue by Type (2011-2021)
Table Global Liver Disease Drug Revenue Share by Type (2011-2021)
Figure Global Liver Disease Drug Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Liver Disease Drug Sales by Application (2011-2021)
Table Global Liver Disease Drug Sales Market Share by Application (2011-2021)
Figure Global Liver Disease Drug Sales Market Share by Application in 2015
Figure Global Liver Disease Drug Sales Market Share by Application in 2021
Table North America Liver Disease Drug Sales by Application (2015 and 2016)
Table Europe Liver Disease Drug Sales by Application (2015 and 2016)
Table China Liver Disease Drug Sales by Application (2015 and 2016)
Table Japan Liver Disease Drug Sales by Application (2015 and 2016)
Table India Liver Disease Drug Sales by Application (2015 and 2016)
Table Southeast Asia Liver Disease Drug Sales by Application (2015 and 2016)
Table Global Liver Disease Drug Sales Growth Rate by Application (2011-2021)
Figure Global Liver Disease Drug Sales Growth Rate by Application (2011-2021)
Table Bayer Schering AG Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Bayer Schering AG (2015 and 2016)
Table Biotest Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Biotest (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Eli Lilly Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Glaxosmithkline PlC Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Glaxosmithkline PlC (2015 and 2016)
Table Merck & Co Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Roche Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
Table Valeant Pharmaceuticals International, Inc Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Valeant Pharmaceuticals International, Inc (2015 and 2016)
Table Chia Tai Tianqing Pharmaceutical Group Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Chia Tai Tianqing Pharmaceutical Group (2015 and 2016)
Table Fujian Cosunter Pharmaceutical Company Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Fujian Cosunter Pharmaceutical Company (2015 and 2016)
Table Beijing Sl Pharmaceutical Co., Ltd. Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Beijing Sl Pharmaceutical Co., Ltd. (2015 and 2016)
Table Inner Mongolia Furui Medical Science Co. Ltd. Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Inner Mongolia Furui Medical Science Co. Ltd. (2015 and 2016)